Filing Details
- Accession Number:
- 0001209191-15-041337
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-11 19:33:24
- Reporting Period:
- 2015-05-11
- Filing Date:
- 2015-05-11
- Accepted Time:
- 2015-05-11 19:33:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1516479 | Insys Therapeutics Inc. | INSY | Pharmaceutical Preparations (2834) | 510327886 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1124179 | J Steven Meyer | C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-05-11 | 18,000 | $3.25 | 23,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-11 | 16,400 | $57.14 | 6,600 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-05-11 | 1,600 | $56.29 | 5,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-05-11 | 18,000 | $0.00 | 18,000 | $3.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,425 | 2021-03-27 | No | 4 | M | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.64 to $57.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.79 to $56.59 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The exercise price reflects a 3-for-2 stock split effected by the Issuer on March 28, 2014
- The option is fully vested and exercisable.
- On March 28, 2014, the Issuer effected a 3-for-2 stock split, resulting in the reporting person's ownership of 11,475 additional options.
Billionaire Hedge Funds
